Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2022

View Archived Issues

FKBP51 blockade ameliorates cognitive function during obesity

New antibacterials described by the Centre National de la Recherche Scientifique (CNRS)

Bayer discovers soluble guanylate cyclase activators

Cancer Research Technology presents new ALDH1A3 inhibitors

LG Chem identifies new proteasome inhibitors

Scripps Research Institute, Vova Ida Therapeutics patent compounds for treating neurodegeneration

CM-1758 shows cytotoxic effects in models of bladder cancer

PXL-065 demonstrates efficacy in preclinical models of ALD

PP2A inhibition sensitizes cancer cells and inhibits their growth

Biomea's menin inhibitor BMF-219 shows prolonged glycemic control in two rat models of diabetes

Noggin expression has prognostic value in pancreatic cancer

First female-specific Alzheimer's risk gene found

Anti-MASP-2 antibody TST-004 shows promise for MASP-2-dependent diseases in vitro and in vivo

Polysaccharide-protein antigen pneumococcal vaccine effective in type 3 invasive disease model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...